IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone
Article in Oncoscience (February 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in Oncoscience (February 2024)
Article in Frontiers in Cardiovascular Medicine (January 2024)
Article in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (December 2023)